key: cord-0846896-s72uq48i authors: Shyam Klinton, Joel; Oga-Omenka, Charity; Heitkamp, Petra title: TB and COVID - Public and private health sectors adapt to a new reality date: 2020-10-29 journal: J Clin Tuberc Other Mycobact Dis DOI: 10.1016/j.jctube.2020.100199 sha: f055c9a7a144403edbe1feceacf5718b1dee0fac doc_id: 846896 cord_uid: s72uq48i Health systems across the world have been baffled by the COVID19 pandemic. Tuberculosis (TB) care and prevention especially in high burden countries has faced disruption to their routine services. Though these setbacks were predicted by many modelling studies, reports and surveys from the field convey the hard reality faced by the TB services. However, health systems have not given up and have become resilient by adapting interesting strategies to overcome these obstacles. The private health sector has also stepped up to the occasion by supporting national TB programs through innovative approaches. The scientific community has laid down several evidence-based recommendations to help TB programs get back on track. Its time to unite these forces to not just overcome the challenge posed by the pandemic but also to build a more resilient health system. Tuberculosis care programs, especially in low resource, high-burden countries have historically struggled to integrate public and private sector. Although, the private sector is often the first point of care for TB patients in many high-burden countries, their oversight and regulation frequently fall outside the purview of National TB programs. Not surprising, countries with a very large private sector were responsible for the largest gaps in TB case notification in 2018 (Stallworthy et al., 2020 , WHO, 2019 , WHO, 2018 . As countries continue to fight the COVID-19 pandemic, integrating public and private sector care for TB has become even more critical. It is noteworthy that public and private sector programs in several high-burden TB countries are beginning to adapt to the situation, as we highlight in our report. We also present several opportunities in the COVID-19 pandemic that can be harnessed for improving TB care. As COVID-19 began to spread rapidly across countries, several models predicted its impact on healthcare services, especially in low-and middle-income countries, where underfunded health services were barely coping with pre-pandemic public health needs (Bhargava and Shewade, 2020 , Hogan et al., 2020 , McQuaid et al., 2020 , StopTB Partnership, 2020a . Some of these modeling studies also included the effect of COVID-19 on TB services. They predicted an increase in TB deaths of between 350,000 and 1.5 million deaths in 5 years deaths; as well as disruptions in case finding and treatment services (Bhargava and Shewade, 2020 , Hogan et al., 2020 , McQuaid et al., 2020 , StopTB Partnership, 2020a . These predictions have since turned out to be self-fulfilling prophesies, as reports from several countries have now shown. Healthcare for many infectious diseases and routine services, particularly TB, HIV and malaria, as well as immunization and maternal and child healthcare, have been severely impacted, as patients battle increased costs of access to fewer services with fewer resources (Abdela et al., 2020 , Ashish et al., 2020 , Gates Foundation, 2020 , Ridgway et al., 2020 . In the midst of these, public and private health sectors struggle to adapt, with varying degrees of success. We examine some lessons, obstacles and opportunities to COVID-19 healthcare adaptation, with particular focus on TB care. In many reports, the COVID-19 pandemic has severely disrupted TB control and its related services. A survey conducted by the global fund in 106 countries in June 2020, identified 78% of TB programs reported disruption to service delivery (17% with high or very high disruptions) (GFATM, 2020a). In a pulse survey by WHO among 105 countries, 42% reported disruptions in their tuberculosis services (WHO, 2020). There is also now evidence to show that a coinfection with COVID-19 worsens TB disease and increases mortality by damaging lung tissue (Sy et al., 2020) . A recent survey by a global coalition of TB civic societies has contributed to increase awareness of the scale of the disruptions for patients, TB frontline healthcare workers, policy makers, civil and non-governmental organizations and researchers. The results present a dismal picture of diverted healthcare and research resources, as well as political will, from TB to the COVID-19 response, reduced access to services, increasing stigma and poverty, mental health decline, poor infection control measures, and stockouts of essential health products, among other effects (TB Civil Society Organizations, 2020). The survey findings concur with the earlier modeling studies and with reports from the WHO, Global Coalition of TB Activists, Stop TB Partnership, the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), the Global TB Caucus, the Americas TB Coalition, and Stop TB Partnership Indonesia (Cilloni et al., 2020 , GFATM, 2020b , Glaziou, 2020 , StopTB Partnership, 2020a , StopTB Partnership, 2020b . Individual reports from countries also agree with the above surveys. State TB programs within India have reported a drastic fall in the notification rate between January to July 2020 in comparison to the same period in 2019 (Sharma, 2020 , Behera, 2020 , Jain et al., 2020 . Similar reports have emerged from TB programs in several other countries including high burden TB countries like China, South Korea, South Africa, and Nigeria (Kwak et al., 2020 , Liu et al., 2020 , Wu et al., 2020 , Fei et al., 2020 , Dookie et al., 2020 , Adewole, 2020 What is causing the disruption of services? The disruptions, which include a dramatic fall in TB notification rate, are mainly attributed to the causes outlined in Box 1. (TB PPM Learning Network, 2020) How is the public sector adapting to the situation? Countries across the world have adapted to the situation through innovative strategies. A common strategy that countries rely on is the combined screening for COVID19 and TB. In the early stages of the pandemic, STOP TB partnership's Global drug facility rolled out 100,000 Xpert® Xpress SARS-CoV-2 which provides an efficient platform to accelerate testing for the new coronavirus along with diagnosing TB. Most countries have approved the use of GeneXpert for COVID-19 screening. State governments within India are mandating the District TB officers to test COVIDnegative people for TB (Ghosh A, 2020). In some places, accredited social health activists were sent door-to-door to identify people with TB. To support other states who wanted to engage in similar activities, the Ministry of Health and Family welfare of India (MOHFW) released a guidance note for bi-directional screening to screen for TB and COVID in influenza like illness (ILI) and severe acute respiratory infections (SARI) patients (MOHFW, 2020). This was followed by a rapid response plan to mitigate impact of COVID-19 pandemic on TB epidemic, released in early September 2020 (Government of India, 2020) . Bidirectional TB-COVID screening, TB testing for all presumptive ILI/SARI/COVID case, active case-finding and contact tracing were some of the key strategies outlined in the plan for revival of the National TB Elimination Program (NTEP) services COVID-19 / Post COVID-19 scenario (Government of India, 2020) . Indonesia, provinces in South Africa and few other African countries are also experimenting with combined screening (Xinhua, 2020 , Devdiscourse, 2020 . The Government of Indonesia ordered aggressive tracing for both TB and COVID-19 patients together (Xinhua, 2020) . In Kaduna state in Nigeria, the World Health Organization (WHO) in partnership with the State Government and KNCV Tuberculosis Foundation, implemented a mobile diagnostic facility called "Wellness On Wheels" Truck (WOW Truck) to test for both TB and COVID (WHO Africa, 2020) . Similarly, in Bangladesh, The National Tuberculosis Control Programme along with BRAC has implemented a mobile X-ray van initiative to diagnose TB. (Hossain SZ, 2020) It is no doubt that COVID-19 has disrupted daily routine in everyone's lives, more so in the life of TB patients. Transport restriction and lockdown measures to limit the spread of COVID-19 have inadvertently affected those seeking care. The challenge with TB being the long duration of treatment and the need for Directly Observed Therapy (DOTS). In an effort to support patients overcome this hurdle many of the government strategies are now adapting strategies. The government of Zimbabwe established mobile refill centres in Harare where people could refill their anti-tuberculous treatment (ATT) as well as antiretroviral treatment (ART) (Chonzi, 2020) . The Metropolitan Health Services of South Africa established a system of home delivery of TB medication using a city-wide network of community health workers (CHWs) and innovative ways like Uber, bicycles and electric scooters. (Brey et al., 2020) In India, due to the lockdown measures TB patients were not able to commute to civic authorities to collect their monthly incentives for treatment completion. The Thane Municipal Corporation (TMC) initiated steps to ensure TB patients receive their incentives of Rs. 500 as this would financially support them during these dire times (TNN, 2020). Telemedicine practices have multiplied during the COVID-19 pandemic. Governments have utilized such digital platforms too, to support TB services during the pandemic. TB patients in India are now able to avail the free OPD services to consult with doctors (National Health Mission -Tamil Nadu, 2020). India's notification portal now includes messaging and Whatsapp options on their patient page to facilitate easy tracing of patients during COVID-19. The private sector, though traditionally viewed as an independent entity working in silos, have also stepped up to support the government efforts during the pandemic. In addition to opening their doors to support the public health officials in treating COVID-19, the private sector in several countries have come up with innovative strategies to support TB services during the pandemic. A few of these examples are outlined in Box 2. Despite the devastating impact of COVID-19 on TB services, many TB programs and facilities are adapting to the pandemic, presenting a silver lining for the future of TB care and prevention. Several stakeholders, including funders, researchers and implementers have shared ways to overcome the unique challenges while maximizing the opportunities. These recommendations are summarized in Table 1 ( Vasquez N, 2020 , Keene et al., 2020 , Udwadia et al., 2020 , MSF, 2020 , D, 2020 These recommendations are focused on the TB care cascade and do not provide a larger health systems perspective, which will be required to make a proper analysis on the role of the private sector and public sector. It is clear that human rights aspects, finance and health systems and social determinants play a large role in how efforts to End TB will need to be taken to scale. While COVID-19 has negatively impacted global health systems and disrupted services for older epidemics such as TB, it has also highlighted the resilience of systems in some countries and created a demand for innovative strategies and partnerships between the public and private health sector. Several recommendations have been made on how countries can minimize the disruptions caused by the pandemic. The TB community needs to urgently embrace adaptations to COVID-19, using the momentum to re-energize efforts to End TB. Research is also now needed, in addition to reports from the frontlines, to inform what strategies and innovations are working, and why. Immediate investment in operational research and documenting effectiveness of innovations is required to outline specifics of the adaptions in TB care and prevention in both the public and private sector. Essential Healthcare Services in the Face of COVID-19 Prevention: Experiences from a Referral Hospital in Ethiopia Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria Effect of the COVID-19 pandemic response on intrapartum care, stillbirth, and neonatal mortality outcomes in Nepal: a prospective observational study Tb Cotrol In India In The Covid Era The potential impact of the COVID-19 response related lockdown on TB incidence and mortality in India Home delivery of medication during Coronavirus disease Mobile refill for TB, ART patients The potential impact of the COVID-19 pandemic on tuberculosis: a modelling analysis Managing an Epidemic Within a Pandemic Provinces experimenting with combining TB and COVID-19 screening Tuberculosis Elimination in the Era of COVID-19: A Moving Target The impact of the COVID-19 epidemic on tuberculosis control in China. The Lancet Regional Health-Western Pacific, 3, 100032. GATES FOUNDATION. 2020. Goal Keeper's Global Fund Survey: Majority of HIV, TB and Malaria Programs Face Disruptions as a Result of COVID-19 Mitigating the impact of COVID-19 on countries affected by HIV/AIDS, Tuberculosis and Malaria As TB diagnosis sees a fall, states are now testing Covid-negative patients for the disease Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020. medRxiv Rapid Response Plan to mitigate impact of COVID-19 Pandemic on TB Epidemic and National TB Elimination Program (NTEP) activities in India Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study Tuberculosis in the era of COVID-19 in India How COVID-19 could benefit tuberculosis and HIV services in South Africa Effect of COVID-19 on tuberculosis notification Collateral impact of the Covid-19 pandemic on tuberculosis control in The potential impact of COVID-19-related disruption on tuberculosis burden COVID-19: avoiding a 'second tragedy' for those with TB #TB patients can now consult #online with #Doctors by using the free #esanjeevaniopd service HIV Care Continuum and COVID-19 Outcomes Among People Living with HIV During the COVID-19 Pandemic Pandemic may derail India's goal of eradicating tuberculosis Mint Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 100171. STOPTB PARTNERSHIP 2020a. Partnership. 2020 We did a rapid assessment: The TB Response is Heavily Impacted by the COVID-19 Pandemic Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19 The impact of COVID-19 on the TB epidemic: A community perspective Thane Municipal Corporation ensures tuberculosis patients get Rs 500 COVID-19-Tuberculosis interactions: when dark forces collide Engaging private health care providers in TB care and prevention: a landscape analysis. World Health Organization Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report Kaduna State and WHO scale up COVID-19 and TB search with mobile testing in communities Indonesia steps up battle against tuberculosis amid COVID-19 pandemic. Ethical Statement This report was a review of documents, publications and media literature. The report did not involve any participation from human or animal subjects